Dupilumab in Eosinophilic Gastritis

Clinical trial NCT03678545 · COMPLETED

Trial details

NCT number: NCT03678545
Sponsor: Children's Hospital Medical Center, Cincinnati
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Eosinophilic Gastritis Eosinophilic Gastroenteritis

Start date: 2021-05-15
Primary completion: 2024-03-04
Enrollment: 41

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.